138 related articles for article (PubMed ID: 38927027)
1. Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis.
Huang JK; Wu PH; Chen ZF; Liu PY; Kuo CC; Chuang YS; Lu MZ; Kuo MC; Chiu YW; Lin YT
Biomolecules; 2024 May; 14(6):. PubMed ID: 38927027
[TBL] [Abstract][Full Text] [Related]
2. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
[TBL] [Abstract][Full Text] [Related]
3. Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study.
Li L; Xiong Q; Zhao J; Lin X; He S; Wu N; Yao Y; Liang W; Zuo X; Ying C
Am J Clin Nutr; 2020 May; 111(5):1087-1099. PubMed ID: 31942927
[TBL] [Abstract][Full Text] [Related]
4. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
Salminen A
J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
[TBL] [Abstract][Full Text] [Related]
5. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
6. Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential.
Konopelski P; Ufnal M
Curr Drug Metab; 2018; 19(10):883-890. PubMed ID: 29708069
[TBL] [Abstract][Full Text] [Related]
7. Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
Nemet I; Li XS; Haghikia A; Li L; Wilcox J; Romano KA; Buffa JA; Witkowski M; Demuth I; König M; Steinhagen-Thiessen E; Bäckhed F; Fischbach MA; Tang WHW; Landmesser U; Hazen SL
Eur Heart J; 2023 Aug; 44(32):3085-3096. PubMed ID: 37342006
[TBL] [Abstract][Full Text] [Related]
8. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
9. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease.
Zhang P; Wang X; Li S; Cao X; Zou J; Fang Y; Shi Y; Xiang F; Shen B; Li Y; Fang B; Zhang Y; Guo R; Lv Q; Zhang L; Lu Y; Wang Y; Yu J; Xie Y; Wang R; Chen X; Yu J; Zhang Z; He J; Zhan J; Lv W; Nie Y; Cai J; Xu X; Hu J; Zhang Q; Gao T; Jiang X; Tan X; Xue N; Wang Y; Ren Y; Wang L; Zhang H; Ning Y; Chen J; Zhang L; Jin S; Ren F; Ehrlich SD; Zhao L; Ding X
Genome Biol; 2023 Oct; 24(1):226. PubMed ID: 37828586
[TBL] [Abstract][Full Text] [Related]
10. Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production.
Wang Y; Li J; Chen C; Lu J; Yu J; Xu X; Peng Y; Zhang S; Jiang S; Guo J; Duan J
Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 33016221
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the gut microbiota and serum metabolites in postmenopausal women with reduced bone mineral density.
Yan L; Wang X; Yu T; Qi Z; Li H; Nan H; Wang K; Luo D; Hua F; Wang W
Front Cell Infect Microbiol; 2024; 14():1367325. PubMed ID: 38912210
[TBL] [Abstract][Full Text] [Related]
12. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
13. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
[TBL] [Abstract][Full Text] [Related]
14. Impact of environmental characteristics on children's gut microbiota - A pilot study in assessing the role of indoor microbiome and metabolites.
Zhang M; Tang H; Chen Y; Chen Z; Xu Y; Fu X; Sun Y; Zhao Z
Environ Res; 2023 Oct; 234():116114. PubMed ID: 37209986
[TBL] [Abstract][Full Text] [Related]
15. Indolic Structure Metabolites as Potential Biomarkers of Non-infectious Diseases.
Beloborodova NV; Chernevskaya EA; Getsina ML
Curr Pharm Des; 2021; 27(2):238-249. PubMed ID: 33092503
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis.
Su X; Gao Y; Yang R
Cells; 2022 Jul; 11(15):. PubMed ID: 35892593
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
[TBL] [Abstract][Full Text] [Related]
18. Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms.
Liu Y; Pei Z; Pan T; Wang H; Chen W; Lu W
Microbiol Res; 2023 Jul; 272():127392. PubMed ID: 37119643
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiota metabolite indole increases emotional responses and adrenal medulla activity in chronically stressed male mice.
Mir HD; Milman A; Monnoye M; Douard V; Philippe C; Aubert A; Castanon N; Vancassel S; Guérineau NC; Naudon L; Rabot S
Psychoneuroendocrinology; 2020 Sep; 119():104750. PubMed ID: 32569990
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
